Dr. Charles A. Crecelius, MD

Dr. Crecelius practices at Delmar Gardens of Chesterfield in Chesterfield, Missouri.

Dr. Crecelius' NPI, 1215080312, was assigned on January 19, 2007. Dr. Crecelius graduated from Saint Louis University School Of Medicine in 1984. Dr. Crecelius holds Missouri license R7F42.

Dr. Crecelius' primary practice is Delmar Gardens of Chesterfield, at 14805 N Outer 40th Rd, Chesterfield, MO 63017 in Saint Louis County. The practice phone is (636) 532-0150.

Dr. Crecelius' primary practice is Delmar Gardens of Chesterfield in Chesterfield, Missouri. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Crecelius to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Crecelius practices, 2 sites in all. Vendor and product names are available with a free account.

Geriatric medicine is Dr. Crecelius' primary specialty in the NPI Registry, under taxonomy code 207RG0300X. Dr. Crecelius is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Crecelius' licenses on file in 2 states: Missouri and Illinois.

Dmand AI lists anxiety, chest wall injury and non-alzheimer's dementia (chronic) among the conditions Dr. Crecelius treats.

CMS data shows 66 Medicare services from Dr. Crecelius across 2 procedure codes in 2024, for 47 Medicare patients. Medicare paid $2,396 for them. Every service was in an office.

CMS counts 47 Medicare patients who saw Dr. Crecelius in 2024. The largest group is 85 and over, with 23 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Crecelius' median patient age at 76, with 50% women.

In 2024, Dr. Crecelius wrote 181 Medicare Part D claims for 18 patients. 19% of them were for generic drugs. CMS names the drug for 158 of them, across 2 drugs with 11 or more claims each, at $7,635 in total drug cost. In 2023, CMS named 241 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Crecelius for performance year 2024, reported as part of a group.

Dmand AI links 12 papers to Dr. Crecelius, published from 2017 to 2024. 2017 was the busiest year, with 2. The most frequent topics are Nursing Homes, Advanced Practice Nursing and Missouri. Dr. Crecelius has published most often in J Am Med Dir Assoc. Dr. Crecelius' most frequent co-authors are Paul Katz and Richelle J. Koopman, MD.

CMS Open Payments shows 647 general payments to Dr. Crecelius from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Pfizer Inc. paid the most, $956.

Dmand AI lists 2 awards for Dr. Crecelius, most recently CMS Stage 1 EHR in 2013.

Dr. Crecelius graduated from Saint Louis University School Of Medicine in 1984.

Dr. Crecelius is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.